Press Releases
November 5, 2020
TFF Pharmaceuticals and Felix Biotechnology Sign Letter of Intent for a Collaboration, Development and License Agreement
TFF Pharmaceuticals, Inc. and Augmenta Bioworks, Inc. Enter Into a Worldwide Joint Development Agreement for COVID-19 Monoclonal Antibody TherapiesNovember 2, 2020
TFF Pharmaceuticals, Inc. and Augmenta Bioworks, Inc. Enter Into a Worldwide Joint Development Agreement for COVID-19 Monoclonal Antibody Therapies
TFF Pharmaceuticals Announces Third Quarter 2020 Financial Results and Business Update Conference Call on November 5, 2020October 28, 2020
TFF Pharmaceuticals Announces Third Quarter 2020 Financial Results and Business Update Conference Call on November 5, 2020
TFF Pharmaceuticals Announces Positive Preclinical Results with University of Georgia Universal Influenza VaccinesOctober 27, 2020
TFF Pharmaceuticals Announces Positive Preclinical Results with University of Georgia Universal Influenza Vaccines
TFF Pharmaceuticals Expands its cGMP Manufacturing Capabilities with ExpericOctober 26, 2020
TFF Pharmaceuticals Expands its cGMP Manufacturing Capabilities with Experic
TFF Pharmaceuticals Updates Progress of Human Clinical Trial with Tacrolimus Inhalation PowderOctober 20, 2020
TFF Pharmaceuticals Updates Progress of Human Clinical Trial with Tacrolimus Inhalation Powder
TFF Pharmaceuticals Announces Results of Its 2020 Annual Meeting of StockholdersSeptember 30, 2020
TFF Pharmaceuticals Announces Results of Its 2020 Annual Meeting of Stockholders
TFF Pharmaceuticals Comments on Animal Studies in the Development of High Potency Remdesivir as a Dry Powder for Inhalation by Thin Film FreezingSeptember 24, 2020
TFF Pharmaceuticals Comments on Animal Studies in the Development of High Potency Remdesivir as a Dry Powder for Inhalation by Thin Film Freezing
TFF Pharmaceuticals Announces Topline Results of Voriconazole Inhalation Powder Phase 1 Clinical TrialSeptember 15, 2020
TFF Pharmaceuticals Announces Topline Results of Voriconazole Inhalation Powder Phase 1 Clinical Trial
TFF Pharmaceuticals to Participate in Anti-fungal Webinar Presented by Maxim Group LLC on September 17th, 2020September 14, 2020
TFF Pharmaceuticals to Participate in Anti-fungal Webinar Presented by Maxim Group LLC on September 17th, 2020